With more than 30 percent of all deaths due to cardiovascular or cardiac problems, the healthcare industry invests massively to prevent diseases, treat patients and minimize recovery. But innovative implantable cardiovascular devices — stents, valves or pacemakers — are slow to reach the patients because of extensive (pre)-clinical testing and necessary compliance with the regulatory authorities.
Understanding the behavior of a new device is critical to cardiac device engineering, which can benefit greatly from medical engineering simulation or in silico medicine.
Reliable computer modeling helps researchers to confidently invent and improve implantable materials that co-exist (without complications) with organs, tissues and blood.
ANSYS simulation software uniquely integrates fluid, structural, thermal and electromagnetics analyses into a single environment, providing insight into how cardiovascular devices behave within the human body.